0000899243-16-017929.txt : 20160411 0000899243-16-017929.hdr.sgml : 20160411 20160411174738 ACCESSION NUMBER: 0000899243-16-017929 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160407 FILED AS OF DATE: 20160411 DATE AS OF CHANGE: 20160411 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seres Therapeutics, Inc. CENTRAL INDEX KEY: 0001609809 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274326290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 440 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 945 9626 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 440 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Seres Health, Inc. DATE OF NAME CHANGE: 20140603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COOK DAVID N CENTRAL INDEX KEY: 0001233684 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37465 FILM NUMBER: 161565977 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-04-07 0 0001609809 Seres Therapeutics, Inc. MCRB 0001233684 COOK DAVID N C/O SERES THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Scientific Officer & EVP Common Stock 2016-04-07 4 S 0 8000 31.00 D 160673 D The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2016. /s/ Roger J. Pomerantz, Attorney-in-Fact 2016-04-11